5 Biotech Stocks to Buy for 2018 Many investors have fallen in love with the potential of biotechnology lately — and for good reason. Exciting companies are fighting some of the most sinister diseases of our time, from cancer to Alzheimer’s. And when drug trials post favorable results, select biotech stocks can see 20%, 50% or even 100% gains in a matter of weeks! Additionally, the sector has started a buyout frenzy in 2018 with a few big-time acquisitions already. Consider that in mid-January, Celgene purchased Juno Therapeutics for $9 billion and delivered shareholders an 80% profit in a SINGLE DAY! But despite all this, some investors remain intimidated or confused by how to play this high-octane sector. Let me help. I’ve crafted a FREE research report, “The 5 Best Biotech Stocks for 2018,” which will help you tap into powerful biotech profits without aggressive or risky strategies. In this report, you’ll learn about: A researcher that has already seen shares double in the last year, and could surge in 2018 on its “triple threat” treatment regimen for cystic fibrosis. A breakout stock that may have the first-ever breast cancer blockbuster! A high-growth biotech stock that is already incredibly profitable and can grow annual revenue at 15% to 20%, even without new FDA approvals! You don’t have to make wild bets on the pharmaceutical industry based on rumors. A close look at FDA approval schedules, past earnings history and acquisition potential will tell you everything you need to know about the best biotech stocks right now. Let me share my five favorite picks with you today — 100% free! — in my new Special Report. But act now, because these time-sensitive recommendations could break out at any time! Jeff Reeves Executive Editor, InvestorPlace.com InvestorPlace Media, LLC. 9201 Corporate Blvd, Suite 200 Rockville, MD 20850

---

This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please go to the following address: http://www.schaeffersresearch.com/schaeffers-unsubscribe-partner?email=indra21poetra@gmail.com Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 250 Cincinnati, Ohio 45242